Pharmaceutical Filtration Market to reach US$ 17 Bn by 2022

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
272
Pharmaceutical Filtration Market to reach US$ 17 Bn by 2022 – Future Market Insights

VALLEY COTTAGE, New York, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market. According to Future Market Insights, the pharmaceutical filtration market is expected to record a robust CAGR of 6.1% for the period from 2017 to 2022.

Global Market Research Report Overview on Pharmaceutical Filtration @ https://www.futuremarketinsights.com/reports/...ion-market

Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward

The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe.

View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/...market/toc

In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022

A Sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/...ep-gb-5028

North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022

The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.

Buy Pharmaceutical Filtration Market Report@ https://www.futuremarketinsights.com/checkout/5028

About Us  

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: sales@futuremarketinsights.com Website: http://www.futuremarketinsights.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading